Amgen Inc Stock Alpha and Beta Analysis

AMGN Stock  USD 295.17  5.27  1.82%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Amgen Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Amgen over a specified time horizon. Remember, high Amgen's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Amgen's market risk premium analysis include:
Beta
0.98
Alpha
(0.28)
Risk
1.57
Sharpe Ratio
(0.10)
Expected Return
(0.16)
Please note that although Amgen alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Amgen did 0.28  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Amgen Inc stock's relative risk over its benchmark. Amgen Inc has a beta of 0.98  . Amgen returns are very sensitive to returns on the market. As the market goes up or down, Amgen is expected to follow. At this time, Amgen's Price Book Value Ratio is very stable compared to the past year. As of the 22nd of November 2024, Price Fair Value is likely to grow to 25.96, while Book Value Per Share is likely to drop 10.26.

Enterprise Value

53.94 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Amgen Backtesting, Amgen Valuation, Amgen Correlation, Amgen Hype Analysis, Amgen Volatility, Amgen History and analyze Amgen Performance.

Amgen Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Amgen market risk premium is the additional return an investor will receive from holding Amgen long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Amgen. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Amgen's performance over market.
α-0.28   β0.98

Amgen expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Amgen's Buy-and-hold return. Our buy-and-hold chart shows how Amgen performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Amgen Market Price Analysis

Market price analysis indicators help investors to evaluate how Amgen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Amgen shares will generate the highest return on investment. By understating and applying Amgen stock market price indicators, traders can identify Amgen position entry and exit signals to maximize returns.

Amgen Return and Market Media

The median price of Amgen for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 319.24 with a coefficient of variation of 3.98. The daily time series for the period is distributed with a sample standard deviation of 12.64, arithmetic mean of 317.53, and mean deviation of 8.55. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
 
Amgen dividend paid on 6th of September 2024
09/06/2024
1
Fiducient Advisors LLC Decreases Stock Position in Amgen Inc.
10/31/2024
2
Vitrian Closes on 50M Initial Investment into Biomanufacturing Capacity in Central Ohio and Launches Partnership with AmplifyBio
11/05/2024
3
Bensler LLC Purchases 1,472 Shares of Amgen Inc.
11/08/2024
4
Whats Happening With Amgen Stock
11/13/2024
5
2 Dividend Stocks to Buy Hand Over Fist in November
11/14/2024
6
BeiGene anuncia los resultados financieros del tercer trimestre de 2024 y otras novedades corporativas
11/15/2024
7
Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 and CT-P47 at American College of Rheu...
11/18/2024
8
Celiac Disease Pipeline Grows as 25 Key Pharma Companies Join the Fight for Innovative Treatments DelveInsight
11/19/2024
9
AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
11/20/2024

About Amgen Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Amgen or other stocks. Alpha measures the amount that position in Amgen Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Dividend Yield0.03130.02970.02960.0185
Price To Sales Ratio4.945.375.479.47

Amgen Upcoming Company Events

As portrayed in its financial statements, the presentation of Amgen's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amgen's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Amgen's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Amgen. Please utilize our Beneish M Score to check the likelihood of Amgen's management manipulating its earnings.
6th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Amgen

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Amgen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Amgen technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Amgen trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...